Emerging evidence supports that tau function is essential for normal synaptic mechanisms and it may be dysregulated in AD potentially through interaction with genetic risk factors in an Aβ-dependent or Aβ-independent manner (Dourlen et al., 2019). This evidence concerns the gene MAPT and Alzheimer disease.